Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas

被引:0
|
作者
Ohnishi, H
Kawamura, M
Hanada, R
Kaneko, Y
Tsunoda, Y
Hongo, T
Bessho, F
Yokomori, K
Hayashi, Y
机构
[1] UNIV TOKYO, FAC MED, DEPT PEDIAT, BUNKYO KU, TOKYO 113, JAPAN
[2] UNIV TOKYO, DEPT PEDIAT SURG, TOKYO, JAPAN
[3] SAITAMA CHILDRENS MED CTR, DEPT HEMATOL & ONCOL, IWATSUKI, SAITAMA, JAPAN
[4] SAITAMA CANC CTR HOSP, DEPT LAB MED, INA, SAITAMA, JAPAN
[5] SHOWA UNIV, SCH MED, DEPT SURG, TOKYO 142, JAPAN
[6] HAMAMATSU UNIV SCH MED, DEPT PEDIAT, SHIZUOKA, JAPAN
来源
GENES CHROMOSOMES & CANCER | 1996年 / 15卷 / 03期
关键词
D O I
10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the mutation of the TP53 gene in hepatoblastomas (HBLs) by using polymerase chain reaction-single strand conformation polymorphism and direct sequencing in 38 HBL tumor samples and in two HBL cell lines. We detected the TP53 gene mutation in an anaplastic hepatoblastoma cell line, but no aberration of the TP53 gene (exons 5-9) was found in tumor samples and in the other HBL cell line. The mutation of the cell line was a missense mutation from GAC (asparagine) to CAC (histidine) at codon 281, which was different from the G-to-T transversion of codon 249 that is frequently found in adult hepatocellular carcinomas (HCCs). In addition, we performed Southern blot analysis of the MDM2 gene, but we did not find MDM2 gene amplification in 19 cases tested. Our results suggest that, in contrast to the findings in HCCs in adults, TP53 gene aberrations are not involved in the development or progression of HBLs in children. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [41] TP53 status and gene amplification in human colorectal carcinomas
    Soulié, P
    Fourme, E
    Hamelin, R
    Asselain, B
    Salmon, RJ
    Dutrillaux, B
    Muleris, M
    CANCER GENETICS AND CYTOGENETICS, 1999, 115 (02) : 118 - 122
  • [42] Genetic evaluation in TP53 and MDM2 as modifier genes for congenital aniridia
    Fernandes-Lima, Zuleide Silva
    Fraga, Lucas Rosa
    Wachholz, Gabriela Elis
    Schuler-Faccini, Lavinia
    Boquett, Juliano Andre
    GENE REPORTS, 2018, 13 : 235 - 236
  • [43] Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene
    Ashraf F Nasr
    Michele Nutini
    Barbara Palombo
    Emanuela Guerra
    Savenio Alberti
    Oncogene, 2003, 22 : 1668 - 1677
  • [44] Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene
    Nasr, AF
    Nutini, M
    Palombo, B
    Guerra, E
    Alberti, S
    ONCOGENE, 2003, 22 (11) : 1668 - 1677
  • [45] TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
    Zajac, Agnieszka
    Smolarz, Beata
    Stachowiak, Grzegorz
    Wilczynski, Jacek R.
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 6
  • [46] TP53, MDM2, NQO1, and Susceptibility to Cervical Cancer
    Hu, Xiaoxia
    Zhang, Zhengyan
    Ma, Duanduan
    Huettner, Phyllis C.
    Massad, L. Stewart
    Nguyen, Loan
    Borecki, Ingrid
    Rader, Janet S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 755 - 761
  • [47] INFERIOR OVERALL SURVIVAL IN CLL PATIENTS WITH TP53 MUTATIONS AND MDM2 SNP309 POLYMORPHISM
    Linderholm, R. H.
    Willander, K.
    Karlsson, K.
    Soderkvist, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 213 - 214
  • [48] TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women
    Agnieszka Zając
    Beata Smolarz
    Grzegorz Stachowiak
    Jacek R. Wilczyński
    Medical Oncology, 2014, 31
  • [49] Interaction of TP53 and MDM2 gene polymorphisms with breast cancer risk: Results from the Shanghai Breast Cancer Study
    Ye, Chuanzhong
    Shu, Xiao Ou
    Wen, Wanqing
    Courtney, Regina
    Gao, Yu-Tang
    Zheng, Wei
    Cai, Qiuyin
    CANCER RESEARCH, 2009, 69
  • [50] Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
    Yokoyama, R
    Schneider-Stork, R
    Radig, K
    Wex, T
    Roessner, A
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (09) : 615 - 621